Search Results - "GROP, A"
-
1
Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS
Published in Neurology (09-10-2001)“…IV methylprednisolone (IVMP) has been used to treat relapses in patients with relapsing-remitting (RR) MS, but its effect on disease progression is not known…”
Get full text
Journal Article -
2
Epstein–Barr virus is associated with grey matter atrophy in multiple sclerosis
Published in Journal of neurology, neurosurgery and psychiatry (01-06-2009)“…Objective:The aim of the study was to determine whether the presence of anti-Epstein–Barr virus (EBV) antibodies is associated with MRI measures of brain…”
Get full text
Journal Article -
3
A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis
Published in Journal of neurology, neurosurgery and psychiatry (01-06-2001)“…OBJECTIVE (a) To establish whether the cognitive decline of the early phase of relapsing-remitting multiple sclerosis depends on the progression of the burden…”
Get full text
Journal Article -
4
Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy
Published in Multiple sclerosis (01-05-2007)“…Brain atrophy, as assessed by magnetic resonance imaging (MRI), has been correlated with disability in patients with multiple sclerosis (MS). Recent evidence…”
Get full text
Journal Article -
5
MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis
Published in Neuroradiology (01-04-2001)“…Correlation studies between various conventional and non-conventional MRI parameters and cognitive impairment in the early stages of multiple sclerosis (MS)…”
Get full text
Journal Article -
6
Depressive symptoms and MRI changes in multiple sclerosis
Published in European journal of neurology (01-09-2002)“…To determine whether changes in specific regions of the brain can contribute to the development of depression in patients with multiple sclerosis (MS). We…”
Get full text
Journal Article -
7
I nterferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy
Published in Multiple sclerosis (01-05-2007)“…Background Brain atrophy, as assessed by magnetic resonance imaging (MRI), has been correlated with disability in patients with multiple sclerosis (MS). Recent…”
Get full text
Journal Article -
8
Single-breath method for assessing the viscoelastic properties of the respiratory system
Published in The European respiratory journal (01-11-1998)“…In order to explain the time dependency of resistance and elastance of the respiratory system, a linear viscoelastic model (Maxwell body) has been proposed. In…”
Get full text
Journal Article -
9
Gene–environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis
Published in Journal of neuroimmunology (30-04-2009)“…Abstract Purpose To determine the role of gene–environmental interactions between the Class I and Class II HLA alleles and the humoral anti-Epstein–Barr Virus…”
Get full text
Journal Article -
10
Frontal parenchymal atrophy measures in multiple sclerosis
Published in Multiple sclerosis (01-10-2004)“…The aim of this study was to establish whether, in a cross-sectional study, the normalized measures of whole and regional brain atrophy correlate better with…”
Get full text
Journal Article -
11
Short-term brain atrophy changes in relapsing–remitting multiple sclerosis
Published in Journal of the neurological sciences (30-08-2004)“…The objective of this study was to establish whether the time interval of 3 months is sufficient to detect whole-brain atrophy changes in patients with…”
Get full text
Journal Article -
12
MMP-9 microsatellite polymorphism and multiple sclerosis
Published in Journal of neuroimmunology (01-07-2004)“…A polymorphism (PM) in the microsatellite of the promoter region of matrix metalloproteinase 9 (MMP-9), modulating its expression, could play a role in…”
Get full text
Journal Article -
13
HLA B7/A2, Epstein-Barr Virus antibodies and magnetic resonance imaging in multiple sclerosis: a case for gene-environment interactions
Published in Multiple sclerosis (01-09-2008)“…Background: The underlying gene-gene interactions and gene-environment interactions can potentially cause the heterogeneity in brain inflammation,…”
Get full text
Journal Article -
14
Epstein-Barr virus is associated with gray matter atrophy and lesion injury in multiple sclerosis
Published in Multiple sclerosis (01-09-2008)“…Background: Because Epstein Barr virus (EBV) specifically affects immune cells and is capable of causing the dysimmunity that is a hallmark of multiple…”
Get full text
Journal Article -
15
Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients
Published in Neurological research (New York) (01-04-2006)“…Objectives: To establish the relationship between the presence and titer of virus-specific serum- and cerebrospinal fluid (CSF)-antibodies in multiple…”
Get full text
Journal Article -
16
HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis
Published in Journal of neurology (01-09-2003)“…The objective of the study was to examine the relationship between HLA genotypes and disease severity as measured by brain MRI quantitative markers of…”
Get full text
Journal Article -
17
-
18
β2-microglobulin serum level is not a marker of disease activity in multiple sclerosis
Published in European journal of neurology (01-07-2004)“…Beta2‐microglobulin (β2‐MG) is a pharmacodynamic marker of interferon‐β activity in multiple sclerosis (MS). Its role in the natural course of the disease is…”
Get full text
Journal Article -
19
Normalized regional brain atrophy measurements in multiple sclerosis
Published in Neuroradiology (01-11-2003)“…There is still a controversy regarding the best regional brain atrophy measurements in multiple sclerosis (MS) studies. The aim of this study was to establish…”
Get full text
Journal Article -
20
beta2-microglobulin serum level is not a marker of disease activity in multiple sclerosis
Published in European journal of neurology (01-07-2004)“…Beta2-microglobulin (beta2-MG) is a pharmacodynamic marker of interferon-beta activity in multiple sclerosis (MS). Its role in the natural course of the…”
Get full text
Journal Article